The first major test with humans using a Pfizer Inc. device to inhale insulin found it could safely replace most injections for diabetics, a step toward an elusive goal. The Pfizer tests presented at a meeting of the American Diabetes Association, are important because they are the first solid evidence in humans that the new inhalation approach might work.